Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal CancerAlan P. Venook, Charles D. Blanke, Al B. Benson et al.|JAMA|2017Cited by 891
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)Hedy L. Kindler, Richard M. Goldberg, Donna Niedzwiecki et al.|Journal of Clinical Oncology|2010Cited by 840
Survival after Postoperative Combination Treatment of Rectal CancerH O Douglass, Howard W. Bruckner, C G Moertel et al.|New England Journal of Medicine|1986Cited by 547
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019Samir Gupta, Ndiya Ogba, Dawn Provenzale et al.|Journal of the National Comprehensive Cancer Network|2019Cited by 342
Clinical Cancer Advances 2008: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical OncologyEric P. Winer, Richard L. Schilsky, Julie R. Gralow et al.|Journal of Clinical Oncology|2008Cited by 290